1083
We describe the 2 - year follow - up of an open - label trial ( CT - AMT - 011 - 01 ) of AAV1 - LPL ( S447X ) gene therapy for lipoprotein lipase ( LPL ) deficiency ( LPLD ) , an orphan disease associated with chylomicronemia , severe hypertriglyceridemia , metabolic complications and potentially life - threatening pancreatitis .
 None
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 None